Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for dopamine agonists (compound)
Most Correlated Studies
- B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
- Lutein granulosa cells of polycystic ovarian syndrome subjects treated with cabergoline
- Drug target sets for approved compounds
- HL-60 acute myeloid leukemia cells treated with potential differentiation inducing compounds
- Dendritic cell gene expression profiles induced by reactive oxygen species (ROS)
Most Relevant Literature
- Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic.
- Efficacy and safety of dopamine agonists in restless legs syndrome.
- Dopamine agonist use and the risk of heart failure.
- Etiology of OHSS and use of dopamine agonists.
- Levodopa dosage determines adherence to long-acting dopamine agonists in Parkinson's disease.
Most Relevant Clinical Trials
- Switching From Oral Dopamine Agonists to Rotigotine
- Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
- Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects Wi…
- The Influence of Dopamine Agonist Cabergoline on Oocyte Maturation
- Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dop…
